Volume 2 Issue 1 - 2016
Blocking MRP1 may Enhance ER-Stress Induced DNA Damage by an Accumulation of Nuclear LTC4
Paiboon Jungsuwadee*
School of Pharmacy, Fairleigh Dickinson University, USA
*Corresponding Author: Paiboon Jungsuwadee, School of Pharmacy, Fairleigh Dickinson University, NJ 07932, USA.
Received: February 20, 2016; Published: July 06, 2016
Citation: Paiboon Jungsuwadee. “Blocking MRP1 may Enhance ER-Stress Induced DNA Damage by an Accumulation of Nuclear LTC4”. EC Pharmacology and Toxicology 2.1 (2016): 57-59.
The ATP-binding cassette multidrug-resistance associated protein 1 (MRP1 for human, Mrp1 for rodent) was cloned in 1992 by Cole SP., et al [1]. The discovery of MRP1 is significant in cancer resistant field primarily because MRP1 was the second membrane efflux transporter associated with multidrug resistant being identified after the discovery of P-glycoprotein (P-gp) by Juliano RL and Ling V back in 1976 [2]. P-gp confers cancer chemotherapy resistance for multiple structurally unrelated compounds with weakly amphipathic and relatively hydrophobic properties. Similarly, substrates for MRP1 are quite diverse, however, with a narrower substrate recognition spectrum. MRP1 mediates an efflux of endo and xenobiotics that are conjugated with either glutathione (GSH), glucuronide or sulfate. MRP1 also mediates the extrusion of nonconjugate hydrophobic compounds in the presence of GSH. Both P-gp and MRP1 were found to be expressed in several cancer resistant cells.
MRP1 is ubiquitously expressed in various tissues [3-5] and is localized in plasma membrane and intracellular organelles including nuclear envelop [6,7]. The function of MRP1 has been expanding beyond the efflux-transporter mediated chemotherapy resistance. Dvash E., et al, have recently published an article reported that leukotriene C4 (LTC4), a classic MRP1 substrate, plays a major role in triggering oxidative DNA damage and cell death [8]. Independently, studies have shown that doxorubicin-induced oxidative stress causes a more severe nuclear injury in cardiac tissues in mice lacking Mrp1 [9,10]. These studies imply that MRP1 may have a role in regulating cell survival by regulating intracellular levels of LTC4 in addition to mediating cancer resistance.
Endoplasmic reticulum (ER) stress and oxidative DNA damage have been associated with several pathophysiology and pathogenesis of disorders, including cardiovascular diseases and cancers. Triggering of ER stress may occur under variety of conditions, leading to an accumulation of unfold and/or misfolded proteins in the ER and a subsequently activation of the unfolded protein response (UPR). This evolutionarily conserved mechanism is aimed to restore ER homeostasis, however, if sustained the UPR can trigger cell death possibly via URP-induced overexpression of C/EBPγ homologous protein (CHOP), which blocks expression of anti-apoptotic protein, BCL-2 [11,12].
In Brefeldin A-mediated-ER stress model, the ER stress causes a translocation of LTC4 synthesis machinery including 5-lipoxygenase (5-LO), 5-LO activating protein (FLAP) and microsomal glutathione S-transferase 2 microsomal glutathione S-transferase 2 (MGST2) into the nucleus of non-hematopoietic cells, triggering biosynthesis of LTC4 (Figure 1). Knocking down CHOP mRNA significantly attenuated ER-stress induced MGST2 expression and LTC4 synthesis, indicating that MGST2 activation is downstream of CHOP [8]. Intriguingly, ER stress also induces translocation of cysLT receptors (i.e., cysLTR1 and cysLTR2) into the nucleus during death-promoting phase of the UPR [8]. This allows a subsequent interaction between LTC4 and its receptors in the nucleus, resulting in oxidative stress as indicated by an accumulation of reactive oxygen species (ROS). Knocking down mgst2 mRNA or blocking cysLTRs with pranlukast or motelukast abrogates the ER stress induced ROS accumulation and diminished oxidative DNA damage indicated by high levels of 8-hydroxy-2’-deoxy guanosine (8-OHDG) and γ-H2AX [8]. Potentially, the source of ROS being generated in the nucleus is mediated by NADH/NADPH oxidases (NOXs), and more specifically NOX4. In has been demonstrated that NOX4 was found predominantly in the nucleus during ER stress, and the NOX4 has a critical role in Ras-induced DNA damage [8,13]. Knocking down NOX4 mRNA significantly diminishes ER stress-induced ROS production [8].

Figure 1: ER stress-mediated oxidative DNA damage. ER stress induces LTC4 biosynthesis in the nucleus. In a condition that ER stress is sustained, the late unfolded protein response may occur, leading to oxidative stress and DNA damage and cell death. The condition may be enhanced or accelerated if the MRP1 in inhibited. Abbreviations: 5-LO, 5-lipoxygenase; cPLA2, cytosolic phospholipase A2; FLAP, 5-LO activating protein; LTC4, leukotriene C4; MGST2, microsomal glutathione S-transferase 2; MRP1, multidrug-resistance associated protein 1.
LTC4 is the potent lipid mediator and is associated with pathophysiology of asthma. In allergic asthma model, airway inflammation in mice lacking Mrp1 was significantly less severe than that in wild-type littermates. This study indicates that Mrp1 plays a pivotal role in the development of airway inflammation through regulation of antigen-specific IgE mediated LTC4 extrusion from sensitized mast cells [14]. It was suggested that inhibition of MRP1 could be beneficial in controlling cellular damage. Surprisingly, blockade of MRP1 in Brefeldin Amediated ER stress model revealed that an accumulation of ROS was more pronounced that in the vehicle treatment control. These studies suggest that the localization of MRP1 is critical in determining the outcomes of the treatment interventions. Blocking MRP1-mediated LTC4 efflux may prevent inflammation because less of the inflammatory mediators will be release from cells such as mast cells. However, blocking MRP1 that are localized in the nuclear membrane envelop may enhance oxidative damage due to an accumulation of LTC4 in the nucleus. This situation can be further exemplified in chemotherapeutic agents that induce ER and oxidative stress.
Chemotherapeutic agents such as doxorubicin, vincristine and 5-fluorouracil are known to cause oxidative stress. Not to surprise, doxorubicin has been shown to be capable of inducing the expression of CHOP, LTC4 synthesis machinery, LTC4 receptors, and translocating them to the nucleus [8]. The nuclear damage induced by doxorubicin was more pronounce in MRP1 deficient mice than that in wildtype littermates [9], indicating that the Mrp1 play an important role in protecting nucleus from ER stress and oxidative stress especially when the insults are from within the nucleus. Thus, blocking MRP1 may enhance ER-stress induced DNA damage by an accumulation of toxic substances including LTC4 in the nucleus.
In summary, the physiologic roles of MRP1 seems to be more diverse than predicted. The function of MRP1 that most recognized by the scientific community is as a plasma membrane efflux transporter for glutathione, glucuronide and sulfate conjugated compounds. This MRP1 function involves metabolisms and pharmacokinetics of diverse xenobiotics and hence drug efficacy and toxicity. As the substrates for MRP1 expand from small molecules to endogenous compounds, many of which are lipid mediators and signaling molecules, it is conceivable that MRP1 has emerged as a membrane transporters impact drug metabolism and detoxification process to a broader range of biologic processes that involve cell survival and pathophysiology of diseases.
  1. Cole SP., et al. “Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line”. Science 258.5088 (1992): 1650-1654.
  2. Juliano RL., et al. “A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants”. Biochimica et Biophysica Acta 455.1 (1976): 152-162.
  3. Flens MJ., et al. “Tissue distribution of the multidrug resistance protein”. American Journal of Pathology 148.4 (1996): 1237-1247.
  4. Jungsuwadee P., et al. “Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice”. Molecular Cancer Therapeutics 5.11 (2006): 2851-2560.
  5. Rao VV., et al. “Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier”. USA 96.7 (1999): 3900-3905.
  6. Cai B., et al. “Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman’s rank correlation analysis”. PLoS One 8.8 (2013): e69611.
  7. Jungsuwadee P., et al. “Mrp1 localization and function in cardiac mitochondria after doxorubicin”. Molecular Pharmacology 75.5 (2009): 1117-1126.
  8. Dvash E., et al. “Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage”. Nature Communications 6.10112 (2015): 1-15.
  9. Deng J., et al. “Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice”. Journal of Pharmacology and Experimental Therapeutics 355.2 (2015): 272-279.
  10. Zhang W., et al. “Loss of Mrp1 potentiates doxorubicin-induced cytotoxicity in neonatal mouse cardiomyocytes and cardiac fibroblasts”. Toxicological Sciences 151.1 (2016): 44-56.
  11. Xu C., et al. “Endoplasmic reticulum stress: cell life and death decisions”. Journal of Clinical Investigation 115.10 (2005): 2656-2564.
  12. Szegezdi E., et al. “Mediators of endoplasmic reticulum stress-induced apoptosis”. EMBO Reports 7.9 (2006): 880-885.
  13. Weyemi U., et al. “The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses”. Mutation Research 751.2 (2012): 77-81.
  14. Yoshioka M., et al. “Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammation”. American Journal of Physiology Lung Cellular and Molecular Physiology 296.1 (2009): L30-36.
Copyright: © 2016 Paiboon Jungsuwadee. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for October Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the November issue of respective journals. Submissions are accepted on/before October 07, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk